Literature DB >> 10951738

ACE inhibitors and high-risk patients.

K A Myers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10951738      PMCID： PMC80335     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Authors:  L Hansson; L H Lindholm; L Niskanen; J Lanke; T Hedner; A Niklason; K Luomanmäki; B Dahlöf; U de Faire; C Mörlin; B E Karlberg; P O Wester; J E Björck
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

Review 2.  Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

Authors:  E M Lonn; S Yusuf; P Jha; T J Montague; K K Teo; C R Benedict; B Pitt
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.